CTOs on the Move

Epocrates

www.epocrates.com

 
Epocrates, Inc. is a provider of clinical information and decision support tools to healthcare professionals, as well as interactive information services to the healthcare industry. As of April 17, 2008, the Company has subscriber base of over 500,000
  • Number of Employees: 250-1000
  • Annual Revenue: > $1 Billion
  • www.epocrates.com
  • 311 Arsenal Street Watertown
    San Mateo, MA USA 02472
  • Phone: 888.807.2076

Executives

Name Title Contact Details

Similar Companies

Virtual Reality Medical Center

Virtual Reality Medical Center is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Volpara Solutions

Volpara Health Technologies Limited is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices. Volpara Health Technologies Limited (formerly Matakina Technology Limited) is a research, development, and manufacturing company based in Wellington, New Zealand. With a diverse research team led by internationally recognized experts in medical physics, as well as proprietary medical imaging technology covered by multiple patents and trademarks, we apply science to the solving of clinical problems around the world. Volpara Health Technologies Limited holds certification to ISO13485 and is a US FDA–registered establishment whose products are listed accordingly. In addition, our products hold CE Marking under European Medical Device Directive 93/42/EEC. Volpara Solutions Limited is our wholly owned sales and marketing subsidiary.

Proven Process Medical Devices

Proven Process Medical Devices is a Mansfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Impel NeuroPharma

Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.

Healthcare Management Systems

Since 1984, HMS has been the leader in hospital information systems focusing on rural, community, behavioral, rehabilitation and multi-entity healthcare organizations.